Status:

TERMINATED

Antenatal Rescue Course of Glucocorticoids in Threatened Premature Birth

Lead Sponsor:

University of Oulu

Conditions:

Respiratory Distress Syndrome

Intraventricular Haemorrhage

Eligibility:

All Genders

Phase:

PHASE4

Brief Summary

Administration of steroid to the mother in imminent preterm delivery is a known effective practice to decrease the risk of respiratory distress syndrome and intraventricular haemorrhage in preterm inf...

Detailed Description

RANDOMIZED TRIAL ON EFFICACY AND SAFETY OF THE ANTENATAL RESCUE COURSE OF GLUCOCORTCOID IN THREATENED PREMATURE BIRTH (ACG trial) Introduction Prematurity is the main cause of neonatal mortality and...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • The pregnant women will be eligible for the trial entry if all following criteria are met:
  • administration of a course of antenatal corticosteroid at least 7 days before the trial entry
  • gestational age is less than 33.0 weeks 6 days\*
  • very high risk of premature delivery\*\*
  • none of the following therapies complications or therapies maternal long term systemic corticosteroid therapy severe clinical chorioamnionitis (maternal fever, increased CRP or another acute phase protein, uterine tenderness) lethal disease of the fetus
  • informed consent obtained
  • premature rupture of membranes is not contraindication for the trial entry
  • \*Gestational age will be calculated from the mother's last menstrual period and confirmed by ultrasound before 20 weeks' gestation. In case the discrepancy in the estimates exceeds two weeks, ultrasound date is accepted.
  • \*\*Very high risk of premature delivery is described as follows:
  • elective delivery within within 4-48 hours, as indicated by the obstetrician on the basis of the clinical status of the mother and/or the fetus
  • very high risk of spontaneous delivery within 4-48 hours, i.e.
  • cervix is open \> 3 cm
  • contractions of the uterus at 5-10 min intervals
  • rupture of the membranes after the first course of ANC
  • fetal and/or maternal indication for elective premature delivery or cesarean section

Exclusion

    Key Trial Info

    Start Date :

    May 1 2001

    Trial Type :

    INTERVENTIONAL

    End Date :

    Estimated Enrollment :

    440 Patients enrolled

    Trial Details

    Trial ID

    NCT00295464

    Start Date

    May 1 2001

    Last Update

    May 3 2006

    Active Locations (10)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 3 (10 locations)

    1

    Helsinki University Central Hospital, Finland

    Helsinki, Finland, 00029 HUS

    2

    Joensuu Central Hospital

    Joensuu, Finland

    3

    Jyväskylä Central Hospital

    Jyväskylä, Finland

    4

    Kuopio University Central Hospital

    Kuopio, Finland